Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
OceanFirst Financial
OCFC
$1.94B
| $336K | ﹤0.01% |
13,166
+750
| +6% | +$18K |
|
|
RCM
2302
DELISTED
R1 RCM Inc. Common Stock
RCM
| $327K | ﹤0.01% |
25,148
+4,670
| +23% | +$53.3K |
|
|
AAMI
2303
Acadian Asset Management
AAMI
$3.28B
| $325K | ﹤0.01% |
31,854
-599
| -2% | -$5.84K |
|
|
INOV
2304
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $325K | ﹤0.01% |
17,268
+3,218
| +23% | +$53.9K |
|
2305
First Bancorp
FBNC
$2.67B
| $320K | ﹤0.01% |
8,018
| – | – |
|
2306
Fomento Económico Mexicano
FMX
$41.9B
| $318K | ﹤0.01% |
3,364
-162,511
| -98% | -$14.9M |
|
2307
GoPro
GPRO
$128M
| $317K | ﹤0.01% |
73,195
+5,907
| +9% | +$24.5K |
|
2308
Nokia
NOK
$53.3B
| $314K | ﹤0.01% |
84,645
| – | – |
|
2309
StoneCo
STNE
$2.71B
| $312K | ﹤0.01% |
+7,833
| New | +$287K |
|
|
CCF
2310
DELISTED
Chase Corporation
CCF
| $309K | ﹤0.01% |
2,602
+288
| +12% | +$33.4K |
|
2311
Hamilton Lane
HLNE
$5.47B
| $306K | ﹤0.01% |
5,133
+860
| +20% | +$49.7K |
|
2312
Karyopharm Therapeutics
KPTI
$43.5M
| $306K | ﹤0.01% |
1,067
+183
| +21% | +$39.7K |
|
2313
Domo
DOMO
$179M
| $301K | ﹤0.01% |
13,840
+936
| +7% | +$17.3K |
|
|
SGMO
2314
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $301K | ﹤0.01% |
35,985
+3,330
| +10% | +$30.6K |
|
|
RVNC
2315
DELISTED
Revance Therapeutics, Inc.
RVNC
| $298K | ﹤0.01% |
18,326
+8,294
| +83% | +$129K |
|
2316
TriCo Bancshares
TCBK
$1.85B
| $292K | ﹤0.01% |
7,137
| – | – |
|
2317
Manitowoc
MTW
$523M
| $291K | ﹤0.01% |
16,625
| – | – |
|
2318
Atlanta Braves Holdings Series A
BATRA
$3.4B
| $290K | ﹤0.01% |
9,778
+527
| +6% | +$15K |
|
2319
TherapeuticsMD
TXMD
$24.1M
| $289K | ﹤0.01% |
2,388
+229
| +11% | +$32.9K |
|
|
STFC
2320
DELISTED
State Auto Financial Corp
STFC
| $287K | ﹤0.01% |
9,224
+1,902
| +26% | +$61.3K |
|
|
CSW
2321
CSW Industrials
CSW
$5.57B
| $282K | ﹤0.01% |
3,661
+592
| +19% | +$42.5K |
|
|
LTRPA
2322
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $282K | ﹤0.01% |
38,235
+2,674
| +8% | +$21.5K |
|
2323
Cass Information Systems
CASS
$744M
| $281K | ﹤0.01% |
4,867
+564
| +13% | +$31.6K |
|
2324
Sea Limited
SE
$68.6B
| $281K | ﹤0.01% |
+6,990
| New | +$235K |
|
2325
TG Therapeutics
TGTX
$7.63B
| $281K | ﹤0.01% |
25,359
+4,203
| +20% | +$32K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.